Medical Journals

Effects of the Cooh-terminal Tripeptide Alpha-msh(11-13) on Corneal Epithelial Wound Healing: Role of Nitric Oxide.

Authors:
  • Bonfiglio Vincenza
  • Camillieri Giovanni
  • Avitabile Teresio
  • Leggio Gian Marco
  • Drago Filippo

From: Department of Experimental and Clinical Pharmacology, University of Catania Medical School, Viale A Doria 6, Catania, Italy.

Experimental eye research

  • Publish Date: Dec 2006
  • ISSN: 0014-4835
  • Volume: 83
  • Issue: 6
  • Pages: 1366-72
  • Medium: Print
  • Language: English
  • Citation (JAMA): Bonfiglio Vincenza, Camillieri Giovanni, Avitabile Teresio, et al. Effects of the Cooh-terminal Tripeptide Alpha-msh(11-13) on Corneal Epithelial Wound Healing: Role of Nitric Oxide.. Exp. Eye Res. Dec 2006;83:1366-72

Abstract

It is known that alpha-melanocyte stimulating hormone (alpha-MSH) may exert anti-inflammatory effects and facilitate reparative processes in different tissues. The effective message sequence of alpha-MSH resides in the COOH-terminal tripeptide alpha-MSH(11-13). This study was undertaken to investigate the effects of topical administration of the COOH-terminal tripeptide sequence of alpha-MSH (alpha-MSH(11-13), KPV) on corneal epithelial wound healing in rabbits and the possible role of nitric oxide (NO) in these effects. The whole corneal epithelium was denuded in both eyes by mechanical abrasion. The area of the corneal epithelial defect was stained with fluorescein, photographed, and then measured before the treatment and every 12 h by a computerized software. The mean epithelial wound area and the mean percent of epithelial defect remaining at each follow-up control were compared between experimental groups. Rabbits were topically treated with KPV 1, 5 or 10 mg/ml (30 microl), two drops four times in a day, for 4 days, starting immediately after corneal abrasion, while control animals received topical phosphate-buffered saline as vehicle. In order to study the role of NO in corneal repair processes, the NO donor, sodium nitroprusside (SP, 10 mg/ml, 30 microl) was administered in both eyes, two drops four times in a day, for 4 days. The effects of KPV or SP were challenged by pre-treatment with the nitric oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester (L-NAME, 10 mg/ml, 30 microl) 30 min prior to KPV or SP instillation. The mean percent epithelial defect remaining each time was significantly smaller in animals treated with KPV or SP in comparison to controls. Sixty hours later, eight out of eight (100%) corneas treated with KPV or SP were completely re-epithelized (P<0.05) while none of the corneas treated with placebo were re-epithelized. Pre-treatment with L-NAME inhibited the facilitating effect of KPV on corneal epithelial wound healing process and totally prevented the effect of SP. Rabbit corneal epithelial cells (RCE) in culture were exposed for 1, 6 and 24 h to different KPV concentrations (0.1, 1 and 10 microM) in medium containing 15% foetal bovine serum (FBS). Cell viability was stimulated by 1 and 10 microM concentrations of the substance. Thus, KPV may facilitate corneal epithelial wound healing in rabbits with a mechanism that may involve NO disposition in corneal tissue. However, it is not known whether this mechanism is likely to depend on a direct stimulating repairing activity shared by the entire molecule of alpha-MSH.

Mesh Headings (Keywords): Animals, Cell Proliferation, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Inhibitors, Epithelial Cells, Epithelium, Corneal, Male, Melanocyte-Stimulating Hormones, NG-Nitroarginine Methyl Ester, Nitric Oxide, Nitric Oxide Donors, Nitroprusside, Peptide Fragments, Rabbits, Wound Healing


Check for Full Text / PubMed Unique Identifier (PMID): 16965771


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.